Acquisition 383 Views Xbrane divests Primm Pharma Malin Otmani February 24, 2021 Xbrane Biopharma has entered into …
Clinical Trials 556 Views The last patient has been enrolled in Xbrane’s XPLORE trial Malin Otmani November 15, 2020 Xbrane Biopharma has enrolled all …
In a new job 528 Views Xbrane appoints new Interim CFO Malin Otmani September 29, 2020 Xbrane Biopharma announces that Margareta …
Pharma Business 572 Views Xbrane establishes new lab at Campus Solna Malin Otmani June 8, 2020 In March 2021, Xbrane Biopharma …
Biotech Business 956 Views Xbrane and STADA partner with Bausch + Lomb Malin Otmani May 6, 2020 Xbrane Biopharma and its co-development …
Intellectual Property 670 Views Xbrane files three patent applications Malin Otmani February 26, 2020 Xbrane Biopharma has filed three …
Biotech Business 955 Views Changes in Xbrane’s management team Malin Otmani February 24, 2020 Xbrane Biopharma strengthens its management …
Pharma Business 1618 Views Xbrane Biopharma accelerates development of Xdivane Malin Otmani April 23, 2019 The company has established a …
Biotech Business 1101 Views Spherotide to the Chinese market Malin Otmani February 7, 2018 Xbrane Biopharma and China Resource …
Agreement 1378 Views Xbrane Biopharma signs new agreement Malin Otmani December 21, 2017 The company has signed a …
In a new job 1154 Views Changes in Xbranes management team Malin Otmani December 14, 2017 Xbrane Biopharma announces that Carlo …
New Market 1444 Views Xbrane’s Spherotide granted market authorization in Iran Malin Otmani August 17, 2017 Xbrane Biopharma’s partner Pooyesh Darou …
